[Bioinformatics-Based Screening and Validation of Biomarkers for Sudden Death in Leukemia]

Bowen Liu1, Zhong Zhang2,3,4, Feng Zhang2,3,4

  • 1Department of Hematology, Guangdong Provincial People's Hospital Affiliated to Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Fa Yi Xue Za Zhi
|July 13, 2026
PubMed
Summary

Biomarkers for sudden death in leukemia were identified using bioinformatics, combining blood routine tests and interleukin-6 (IL-6) levels for differential diagnosis. This aids in determining the cause of death in leukemia cases and medical malpractice evaluations.

Related Concept Videos